First In, Last Out | WAMU 88.5 - American University Radio
Filed Under:

First In, Last Out

Play associated audio

On-air challenge: For each word provided, give a word that can follow it to complete a familiar two-word phrase. The first two letters of the provided word should be the last two letters of the answer. Example: Red Square

Last week's challenge: Name certain trees. Also name something that trees have. Rearrange all the letters to get the brand name of a product you might buy at a grocery or drug store. What is it?

Answer: Firs + Leaves = Life Savers

Winner: Nils Thingvall of Lafayette, Colo.

Next week's challenge from Mike Reiss, a writer for The Simpsons: Name a famous actor or actress whose last name ends in a doubled letter. Drop that doubled letter. Then insert an R somewhere inside the first name. The result will be a common two-word phrase. What is it?

Submit Your Answer

If you know the answer to next week's challenge, submit it here. Listeners who submit correct answers win a chance to play the on-air puzzle. Important: Include a phone number where we can reach you Thursday at 3 p.m. Eastern.

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

NPR

From Bond Girl To Medicine Woman: Jane Seymour's Big Break

The actress is best known for her role as Dr. Quinn, the physician on the American frontier. But her big break came years before, when she played 007's tarot-reading love interest in Live and Let Die.
NPR

'Into The Wild' Author Tries Science To Solve Toxic Seed Mystery

Jon Krakauer has long been haunted by how Christopher McCandless died in the Alaskan wilderness. In a scientific journal, he and a chemist show that the seeds McCandless consumed can contain a toxin.
NPR

5 Things You Should Know About Ben Carson

The pediatric neurosurgeon, who entered the presidential race Sunday night, performed pioneering operations on conjoined twins and hasn't held public office before. Here's what you might not know.
NPR

The Promise And Potential Pitfalls Of Apple's ResearchKit

Apple's new mobile software platform is designed to help collect data for medical research, but concerns have been raised about privacy and informed consent.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.